{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:42:48Z","timestamp":1769737368494,"version":"3.49.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"DOI":"10.7759\/cureus.18487","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T10:08:28Z","timestamp":1633428508000},"source":"Crossref","is-referenced-by-count":13,"title":["Impact of Vitamin D Supplementation on Multiple Sclerosis"],"prefix":"10.7759","author":[{"given":"Fenil","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharan","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaithanya","family":"Avanthika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azouba","family":"Gulraiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratiksha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareeha","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger KL","year":"2004","unstructured":"Munger KL, Zhang SM, O'Reilly E, Hern\u00e1n MA, Olek MJ, Willett WC, Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004, 62:60-5. 10.1212\/01.wnl.0000101723.79681.38","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2014.04.021","article-title":"Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis","volume":"570","author":"Duan S","year":"2014","unstructured":"Duan S, Lv Z, Fan X, Wang L, Han F, Wang H, Bi S. Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis. Neurosci Lett. 2014, 570:108-13. 10.1016\/j.neulet.2014.04.021","journal-title":"Neurosci Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1756285612447090","article-title":"Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation","volume":"5","author":"Pierrot-Deseilligny C","year":"2012","unstructured":"Pierrot-Deseilligny C, Rivaud-P\u00e9choux S, Clerson P, de Paz R, Souberbielle JC. Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord. 2012, 5:187-98. 10.1177\/1756285612447090","journal-title":"Ther Adv Neurol Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.014191","article-title":"Influence of diet in multiple sclerosis: a systematic review","volume":"8","author":"Bagur MJ","year":"2017","unstructured":"Bagur MJ, Murcia MA, Jim\u00e9nez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL, Mart\u00ednez-Tom\u00e9 M. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr. 2017, 8:463-72. 10.3945\/an.116.014191","journal-title":"Adv Nutr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese MA","year":"2014","unstructured":"Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol. 2014, 10:225-38. 10.1038\/nrneurol.2014.37","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0394-1","article-title":"Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis","volume":"15","author":"Jelinek GA","year":"2015","unstructured":"Jelinek GA, Marck CH, Weiland TJ, Pereira N, van der Meer DM, Hadgkiss EJ. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis. BMC Neurol. 2015, 15:132. 10.1186\/s12883-015-0394-1","journal-title":"BMC Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.03.014","article-title":"Vitamin D and multiple sclerosis: an update","volume":"14","author":"Pierrot-Deseilligny C","year":"2017","unstructured":"Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord. 2017, 14:35-45. 10.1016\/j.msard.2017.03.014","journal-title":"Mult Scler Relat Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2217\/nmt.15.33","article-title":"Ultraviolet radiation, vitamin D and multiple sclerosis","volume":"5","author":"Lucas RM","year":"2015","unstructured":"Lucas RM, Byrne SN, Correale J, Ilschner S, Hart PH. Ultraviolet radiation, vitamin D and multiple sclerosis. Neurodegener Dis Manag. 2015, 5:413-24. 10.2217\/nmt.15.33","journal-title":"Neurodegener Dis Manag"},{"key":"ref9","unstructured":"Number of people with MS. (2013). http.\/\/www.atlasofms.org."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne P","year":"2014","unstructured":"Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014, 83:1022-4. 10.1212\/WNL.0000000000000768","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000431042","article-title":"Multiple sclerosis epidemiology in Middle East and North Africa: a systematic review and meta-analysis","volume":"44","author":"Heydarpour P","year":"2015","unstructured":"Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA. Multiple sclerosis epidemiology in Middle East and North Africa: a systematic review and meta-analysis. Neuroepidemiology. 2015, 44:232-44. 10.1159\/000431042","journal-title":"Neuroepidemiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000111576","article-title":"The accuracy of prevalence rates of multiple sclerosis: a critical review","volume":"29","author":"Poser CM","year":"2007","unstructured":"Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: a critical review. Neuroepidemiology. 2007, 29:150-5. 10.1159\/000111576","journal-title":"Neuroepidemiology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2011.240432","article-title":"Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis","volume":"82","author":"Simpson S Jr","year":"2011","unstructured":"Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011, 82:1132-41. 10.1136\/jnnp.2011.240432","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1995.tb05853.x","article-title":"MS epidemiology world wide. One view of current status","volume":"161","author":"Kurtzke JF","year":"1995","unstructured":"Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl. 1995, 161:23-33. 10.1111\/j.1600-0404.1995.tb05853.x","journal-title":"Acta Neurol Scand Suppl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.101196","article-title":"Regional variations in the prevalence of multiple sclerosis in French farmers","volume":"78","author":"Vukusic S","year":"2007","unstructured":"Vukusic S, Van Bockstael V, Gosselin S, Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry. 2007, 78:707-9. 10.1136\/jnnp.2006.101196","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507085801","article-title":"Argentine Patagonia: prevalence and clinical features of multiple sclerosis","volume":"14","author":"Melcon MO","year":"2008","unstructured":"Melcon MO, Gold L, Carr\u00e1 A, et al.. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler. 2008, 14:656-62. 10.1177\/1352458507085801","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1017\/s0317167100009380","article-title":"Prevalence of multiple sclerosis in Canada: a systematic review","volume":"35","author":"Poppe AY","year":"2008","unstructured":"Poppe AY, Wolfson C, Zhu B. Prevalence of multiple sclerosis in Canada: a systematic review. Can J Neurol Sci. 2008, 35:593-601. 10.1017\/s0317167100009380","journal-title":"Can J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen N","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010, 9:520-32. 10.1016\/S1474-4422(10)70064-8","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/nejm195205082461901","article-title":"Multiple Sclerosis in Rural Norway","volume":"246","author":"Swank R","year":"1952","unstructured":"Swank R, Lerstad O, Str\u00f8m A, Backer J. Multiple Sclerosis in Rural Norway. N Engl J Med. 1952, 246:721-8. 10.1056\/nejm195205082461901","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton SM","year":"2006","unstructured":"Orton SM, Herrera BM, Yee IM, et al.. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006, 5:932-6. 10.1016\/S1474-4422(06)70581-6","journal-title":"Lancet Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"Beecham AH","year":"2013","unstructured":"Beecham AH, Patsopoulos NA, Xifara DK, et al.. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013, 45:1353-60. 10.1038\/ng.2770","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70267-4","article-title":"Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses","volume":"14","author":"Belbasis L","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015, 14:263-73. 10.1016\/S1474-4422(14)70267-4","journal-title":"Lancet Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston A","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008, 372:1502-17. 10.1016\/S0140-6736(08)61620-7","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer S","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen M, et al.. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011, 476:214-9. 10.1038\/nature10251","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer B","year":"2015","unstructured":"Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015, 14:406-419. 10.1016\/S1474-4422(14)70305-9","journal-title":"Lancet Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka MT","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014, 14:463-77. 10.1038\/nri3705","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou CA","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015, 15:545-58. 10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer MT","year":"2012","unstructured":"Fischer MT, Sharma R, Lim JL, et al.. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012, 135:886-99. 10.1093\/brain\/aws012","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2010.04.009","article-title":"Optic neuritis: a mechanistic view","volume":"18","author":"Burton EV","year":"2011","unstructured":"Burton EV, Greenberg BM, Frohman EM. Optic neuritis: a mechanistic view. Pathophysiology. 2011, 18:81-92. 10.1016\/j.pathophys.2010.04.009","journal-title":"Pathophysiology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198206243062505","article-title":"Membranes, myelin, and the pathophysiology of multiple sclerosis","volume":"306","author":"Waxman SG","year":"1982","unstructured":"Waxman SG. Membranes, myelin, and the pathophysiology of multiple sclerosis. N Engl J Med. 1982, 306:1529-33. 10.1056\/NEJM198206243062505","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger KL","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006, 296:2832-8. 10.1001\/jama.296.23.2832","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.4800","article-title":"Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort","volume":"73","author":"Munger KL","year":"2016","unstructured":"Munger KL, \u00c5ivo J, Hongell K, Soilu-H\u00e4nninen M, Surcel HM, Ascherio A. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort. JAMA Neurol. 2016, 73:515-9. 10.1001\/jamaneurol.2015.4800","journal-title":"JAMA Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003849","article-title":"Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS","volume":"88","author":"Gianfrancesco MA","year":"2017","unstructured":"Gianfrancesco MA, Stridh P, Rhead B, et al.. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017, 88:1623-9. 10.1212\/WNL.0000000000003849","journal-title":"Neurology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24210","article-title":"Neonatal vitamin D status and risk of multiple sclerosis","volume":"76","author":"Ueda P","year":"2014","unstructured":"Ueda P, Rafatnia F, B\u00e4\u00e4rnhielm M, et al.. Neonatal vitamin D status and risk of multiple sclerosis. Ann Neurol. 2014, 76:338-46. 10.1002\/ana.24210","journal-title":"Ann Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.12.009","article-title":"Regulation of the extrarenal CYP27B1-hydroxylase","volume":"144 Pt A","author":"Adams JS","year":"2014","unstructured":"Adams JS, Rafison B, Witzel S, et al.. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol. 2014, 144 Pt A:22-7. 10.1016\/j.jsbmb.2013.12.009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803736","article-title":"Vitamin d-directed rheostatic regulation of monocyte antibacterial responses","volume":"182","author":"Adams JS","year":"2009","unstructured":"Adams JS, Ren S, Liu PT, et al.. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol. 2009, 182:4289-95. 10.4049\/jimmunol.0803736","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu PT","year":"2006","unstructured":"Liu PT, Stenger S, Li H, et al.. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006, 311:1770-3. 10.1126\/science.1123933","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665111003193","article-title":"Vitamin D, invariant natural killer T-cells and experimental autoimmune disease","volume":"71","author":"Cantorna MT","year":"2012","unstructured":"Cantorna MT, Zhao J, Yang L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc. 2012, 71:62-6. 10.1017\/S0029665111003193","journal-title":"Proc Nutr Soc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-012-0421-6","article-title":"Vitamin D status indicators in indigenous populations in East Africa","volume":"52","author":"Luxwolda MF","year":"2013","unstructured":"Luxwolda MF, Kuipers RS, Kema IP, van der Veer E, Dijck-Brouwer DA, Muskiet FA. Vitamin D status indicators in indigenous populations in East Africa. Eur J Nutr. 2013, 52:1115-25. 10.1007\/s00394-012-0421-6","journal-title":"Eur J Nutr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4161\/derm.24494","article-title":"Sunlight and Vitamin D. A global perspective for health","volume":"5","author":"Wacker M","year":"2013","unstructured":"Wacker M, Holick MF. Sunlight and Vitamin D. A global perspective for health. Dermatoendocrinol. 2013, 5:51-108. 10.4161\/derm.24494","journal-title":"Dermatoendocrinol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1313","article-title":"Vitamin D: a new promising therapy for congenital ichthyosis","volume":"137","author":"Sethuraman G","year":"2016","unstructured":"Sethuraman G, Marwaha RK, Challa A, Yenamandra VK, Ramakrishnan L, Thulkar S, Sharma VK. Vitamin D: a new promising therapy for congenital ichthyosis. Pediatrics. 2016, 137:e20151313. 10.1542\/peds.2015-1313","journal-title":"Pediatrics"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2018_246","article-title":"Immunomodulatory role of vitamin D: a review","volume":"1108","author":"Skrobot A","year":"2018","unstructured":"Skrobot A, Demkow U, Wachowska M. Immunomodulatory role of vitamin D: a review. Adv Exp Med Biol. 2018, 1108:13-23. 10.1007\/5584_2018_246","journal-title":"Adv Exp Med Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601952","article-title":"Multiple sclerosis and vitamin D: an update","volume":"58","author":"VanAmerongen BM","year":"2004","unstructured":"VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004, 58:1095-109. 10.1038\/sj.ejcn.1601952","journal-title":"Eur J Clin Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/msj.20246","article-title":"Axonal damage in multiple sclerosis","volume":"78","author":"Haines JD","year":"2011","unstructured":"Haines JD, Inglese M, Casaccia P. Axonal damage in multiple sclerosis. Mt Sinai J Med. 2011, 78:231-43. 10.1002\/msj.20246","journal-title":"Mt Sinai J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.22074\/cellj.2016.4867","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi N","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017, 19:1-10. 10.22074\/cellj.2016.4867","journal-title":"Cell J"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.11138\/fneur\/2017.32.2.083","article-title":"HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family","volume":"32","author":"Mosca L","year":"2017","unstructured":"Mosca L, Mantero V, Penco S, et al.. HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family. Funct Neurol. 2017, 32:83-8. 10.11138\/fneur\/2017.32.2.083","journal-title":"Funct Neurol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041678","article-title":"Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles","volume":"7","author":"Cocco E","year":"2012","unstructured":"Cocco E, Meloni A, Murru MR, et al.. Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles. PLoS One. 2012, 7:e41678. 10.1371\/journal.pone.0041678","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D","volume":"5","author":"Ramagopalan SV","year":"2009","unstructured":"Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al.. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009, 5:e1000369. 10.1371\/journal.pgen.1000369","journal-title":"PLoS Genet"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9074-6","article-title":"Vitamin D for the treatment of multiple sclerosis: a meta-analysis","volume":"265","author":"McLaughlin L","year":"2018","unstructured":"McLaughlin L, Clarke L, Khalilidehkordi E, Butzkueven H, Taylor B, Broadley SA. Vitamin D for the treatment of multiple sclerosis: a meta-analysis. J Neurol. 2018, 265:2893-905. 10.1007\/s00415-018-9074-6","journal-title":"J Neurol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4161\/derm.24808","article-title":"A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis","volume":"5","author":"Finamor DC","year":"2013","unstructured":"Finamor DC, Sinigaglia-Coimbra R, Neves LC, et al.. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013, 5:222-34. 10.4161\/derm.24808","journal-title":"Dermatoendocrinol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human health and disease","volume":"12","author":"Charoenngam N","year":"2020","unstructured":"Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020, 12:2097. 10.3390\/nu12072097","journal-title":"Nutrients"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson AJ","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17:162-73. 10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref53","article-title":"Diagnosis of Multiple Sclerosis in Adults","author":"Olek MJ","year":"2017","unstructured":"Olek MJ, Gonz\u00e1lez-Scarano F, Dashe JF. Diagnosis of Multiple Sclerosis in Adults. Post TW (ed): UpToDate, Waltham, MA; 2017."},{"key":"ref54","article-title":"Practical Neurology","author":"Biller J","year":"2012","unstructured":"Biller J. Practical Neurology. Lippincott Williams & Wilkins, Philadelphia, Pennsylvania; 2012."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.58282","article-title":"Cerebrospinal fluid in multiple sclerosis","volume":"12","author":"Rammohan KW","year":"2009","unstructured":"Rammohan KW. Cerebrospinal fluid in multiple sclerosis. Ann Indian Acad Neurol. 2009, 12:246-53. 10.4103\/0972-2327.58282","journal-title":"Ann Indian Acad Neurol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala JR","year":"2001","unstructured":"Avasarala JR, Cross AH, Trotter JL. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol. 2001, 58:2044-5. 10.1001\/archneur.58.12.2044","journal-title":"Arch Neurol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2015.02.003","article-title":"ACTH: the forgotten therapy","volume":"27","author":"Montero-Melendez T","year":"2015","unstructured":"Montero-Melendez T. ACTH: the forgotten therapy. Semin Immunol. 2015, 27:216-26. 10.1016\/j.smim.2015.02.003","journal-title":"Semin Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis. The 2013 revisions","volume":"83","author":"Lublin FD","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, et al.. Defining the clinical course of multiple sclerosis. The 2013 revisions. Neurology. 2014, 83:278-86. 10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: a review","volume":"133","author":"Hauser SL","year":"2020","unstructured":"Hauser SL, Cree BA. Treatment of multiple sclerosis: a review. Am J Med. 2020, 133:1380-1390.e2. 10.1016\/j.amjmed.2020.05.049","journal-title":"Am J Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02018-8","article-title":"Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis","volume":"138","author":"Hoepner R","year":"2019","unstructured":"Hoepner R, Bagnoud M, Pistor M, et al.. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathol. 2019, 138:443-56. 10.1007\/s00401-019-02018-8","journal-title":"Acta Neuropathol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000622","article-title":"Vitamin D enhances responses to interferon-\u03b2 in MS","volume":"6","author":"Feng X","year":"2019","unstructured":"Feng X, Wang Z, Howlett-Prieto Q, Einhorn N, Causevic S, Reder AT. Vitamin D enhances responses to interferon-\u03b2 in MS. Neurol Neuroimmunol Neuroinflamm. 2019, 6:e622. 10.1212\/NXI.0000000000000622","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio A","year":"2014","unstructured":"Ascherio A, Munger KL, White R, et al.. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014, 71:306-14. 10.1001\/jamaneurol.2013.5993","journal-title":"JAMA Neurol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_208_20","article-title":"Effect of vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): a systematic review and meta-analysis","volume":"12","author":"Hanaei S","year":"2021","unstructured":"Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M. Effect of vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): a systematic review and meta-analysis. Int J Prev Med. 2021, 12:42. 10.4103\/ijpvm.IJPVM_208_20","journal-title":"Int J Prev Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95302","article-title":"Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation","volume":"211","author":"Bhargava P","year":"2017","unstructured":"Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. JCI Insight. 2017, 211:975-85. 10.1172\/jci.insight.95302","journal-title":"JCI Insight"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201505119","article-title":"Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation","volume":"211","author":"de la Fuente AG","year":"2015","unstructured":"de la Fuente AG, Errea O, van Wijngaarden P, et al.. Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. J Cell Biol. 2015, 211:975-85. 10.1083\/jcb.201505119","journal-title":"J Cell Biol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00674-8","article-title":"An update on vitamin D and disease activity in multiple sclerosis","volume":"33","author":"Smolders J","year":"2019","unstructured":"Smolders J, Torkildsen \u00d8, Camu W, Holm\u00f8y T. An update on vitamin D and disease activity in multiple sclerosis. CNS Drugs. 2019, 33:1187-99. 10.1007\/s40263-019-00674-8","journal-title":"CNS Drugs"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102760","article-title":"Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis","volume":"49","author":"Simpson-Yap S","year":"2021","unstructured":"Simpson-Yap S, Jelinek P, Weiland T, Nag N, Neate S, Jelinek G. Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis. Mult Scler Relat Disord. 2021, 49:102760. 10.1016\/j.msard.2021.102760","journal-title":"Mult Scler Relat Disord"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061301","article-title":"Effectiveness of vitamin D supplementation in the management of multiple sclerosis: a systematic review","volume":"20","author":"Berezowska M","year":"2019","unstructured":"Berezowska M, Coe S, Dawes H. Effectiveness of vitamin D supplementation in the management of multiple sclerosis: a systematic review. Int J Mol Sci. 2019, 20:1301. 10.3390\/ijms20061301","journal-title":"Int J Mol Sci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12844","article-title":"Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection","volume":"23","author":"Mowry EM","year":"2016","unstructured":"Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol. 2016, 23:327-32. 10.1111\/ene.12844","journal-title":"Eur J Neurol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002316","article-title":"Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis","volume":"86","author":"Sotirchos ES","year":"2016","unstructured":"Sotirchos ES, Bhargava P, Eckstein C, et al.. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology. 2016, 86:382-90. 10.1212\/WNL.0000000000002316","journal-title":"Neurology"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666201007152230","article-title":"How much vitamin D is too much? A case report and review of the literature","volume":"[Epub ahead of print]","author":"De Vincentis S","year":"2020","unstructured":"De Vincentis S, Russo A, Milazzo M, et al.. How much vitamin D is too much? A case report and review of the literature. Endocr Metab Immune Disord Drug Targets. 2020, [Epub ahead of print]:10.2174\/1871530320666201007152230","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00550","article-title":"Vitamin d toxicity-a clinical perspective","volume":"9","author":"Marcinowska-Suchowierska E","year":"2018","unstructured":"Marcinowska-Suchowierska E, Kupisz-Urba\u0144ska M, \u0141ukaszkiewicz J, P\u0142udowski P, Jones G. Vitamin d toxicity-a clinical perspective. Front Endocrinol (Lausanne). 2018, 9:550. 10.3389\/fendo.2018.00550","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72893-impact-of-vitamin-d-supplementation-on-multiple-sclerosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:54Z","timestamp":1707507054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72893-impact-of-vitamin-d-supplementation-on-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":72,"URL":"https:\/\/doi.org\/10.7759\/cureus.18487","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}